Novonesis
Tracked across 2 events · 12 articles · First seen Aug 10, 2026 · Last active Sep 03, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Novonesis is the acquirer, strengthening its yeast capabilities and R&D as part of its 2030 strategy. The deal is expected to enhance its competitive position in biosolutions.
Aug 10, 2026 · 6 articles
Business
On September 2, 2026, Novonesis announced a €600 million investment to expand its enzyme production facility in Patalganga, India, and build one of the world's most advanced enzyme production plants. The facility, expected to be…
Impact: Novonesis is the investing company, committing €600 million to expand its Patalganga facility. This investment is expected to increase production capacity, support growth in emerging markets, and align with its 2030 financial targets.
Sep 02, 2026 · 6 articles
100
Novonesis announced investmentNovonesis invests 600...
80
Novonesis raised outlookNovonesis invests 600...
75
Novonesis signed agreement to acquire MicroBioGenNovonesis invests 600...
70
Novonesis approved buybackNovonesis invests 600...
60
Novonesis approved dividendNovonesis invests 600...
ERGEN INTELLIGENCE
Track Novonesis live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard